Evidence map›Paper›PMID 40474070›Full record

ArticleBMC microbiology2025

Machine learning based gut microbiota pattern and response to fiber as a diagnostic tool for chronic inflammatory diseases.

Miad Boodaghidizaji, Thaisa Jungles, Tingting Chen, Bin Zhang, Tianming Yao, Alan Landay, Ali Keshavarzian, Bruce Hamaker, Arezoo Ardekani

Abstract read
In one paragraph

Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Recent advances in the positive role ofFrontiers in immunology · 2026
    Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Miad Boodaghidizaji *School of Mechanical Engineering, Purdue University, 585 Purdue Mall, West Lafayette, IN, 47907, USA.
Thaisa Jungles *Department of Food Science, Whistler Center for Carbohydrate Research, Purdue University, West Lafayette, IN, 47907, USA.
Tingting ChenDepartment of Food Science, Whistler Center for Carbohydrate Research, Purdue University, West Lafayette, IN, 47907, USA.
Bin ZhangDepartment of Food Science, Whistler Center for Carbohydrate Research, Purdue University, West Lafayette, IN, 47907, USA.
Tianming YaoDepartment of Food Science, Whistler Center for Carbohydrate Research, Purdue University, West Lafayette, IN, 47907, USA.
Alan LandayDepartments of Internal Medicine, Anatomy and cell biology, and Molecular Biophysics and Physiology, Center for Integrated Microbiome and Chronobiology Research, Rush University Medical Center, Chicago, USA.
Ali KeshavarzianDepartments of Internal Medicine, Anatomy and cell biology, and Molecular Biophysics and Physiology, Center for Integrated Microbiome and Chronobiology Research, Rush University Medical Center, Chicago, USA.
Bruce HamakerDepartment of Food Science, Whistler Center for Carbohydrate Research, Purdue University, West Lafayette, IN, 47907, USA. hamakerb@purdue.edu.
Arezoo ArdekaniSchool of Mechanical Engineering, Purdue University, 585 Purdue Mall, West Lafayette, IN, 47907, USA. ardekani@purdue.edu.

Funding

NIH the National Institutes of Health R44-DK088525
6 · The paper itself

Abstract

Gut microbiota has been implicated in the pathogenesis of multiple gastrointestinal (GI) and systemic metabolic and inflammatory disorders where disrupted gut microbiota composition and function (dysbiosis) has been found in multiple studies. Thus, human microbiome data holds significant potential as a source of information for diagnosing and characterizing diseases-such as phenotypes, disease course, and therapeutic response-associated with dysbiotic microbiota communities. However, multiple attempts to leverage gut microbiota taxonomic data for diagnostic and disease characterization have failed due to significant inter-individual variability of microbiota community and overlap of disrupted microbiota communities among multiple diseases. One potential approach is to look at the microbiota community pattern and response to microbiota modifiers like dietary fiber in different disease states. This approach has become feasible with the advent of machine learning, which can uncover hidden patterns in human microbiome data and enable disease prediction. Accordingly, the aim of our study was to test the hypothesis that machine learning algorithms can distinguish stool microbiota patterns-and their responses to fiber-across diseases with previously reported overlapping dysbiotic microbiota profiles. Here, we applied machine learning algorithms to distinguish between Parkinson's disease, Crohn's disease (CD), ulcerative colitis (UC), human immune deficiency virus (HIV), and healthy control (HC) subjects in the presence and absence of fiber treatments. We demonstrated that machine learning algorithms can classify diseases with accuracy as high as 95%. Furthermore, applying machine learning to microbiome data to distinguish UC from CD yielded a prediction accuracy of up to 90%.

Indexed as

Dietary FiberGastrointestinal MicrobiomeInflammationMachine LearningAlgorithmsBacteriaChronic DiseaseColitis, UlcerativeCrohn DiseaseDysbiosisFecesFemaleHIV InfectionsHumansMaleParkinson DiseaseDietary FiberCrohn's diseaseFiber treatmentMachine learningMicrobiome dataUlcerative colitis

Identifiers

PMID40474070
PMCPMC12143056

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.